Clinical Trials for Constellation Pharmaceuticals

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Constellation Pharmaceuticals

Clinical Trials (2)

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

PHASE3Active, not recruiting

430 participants

Started: Apr 9, 2021 · Completed: Dec 31, 2027

4 conditions1 sponsor156 locations

ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

PHASE1/PHASE2Active, not recruiting

242 participants

Started: Nov 15, 2017 · Completed: Dec 31, 2021

1 condition1 sponsor41 locations